Promethazine
Posted 2 days ago by David ChanPromethazine
ATC Code: R06AD02News Source
Health Canada MedEffectNews Date
April 26, 2010Brief Description
Promethazine is not to be used in children under the age of two years due to the potentially fatal risk of respiratory depression (slowed breathing).
Caution should be used when administering promethazine in children aged two and up: health care professionals are recommended to use the lowest effective dose, and the use of other drugs that may also slow breathing should be avoided.
Promethazine is not to be injected under the skin (subcutaneously) due to the risk of serious tissue injury.
The preferred route of administration for promethazine is by injection directly and deeply into a muscle (deep intramuscular injection). Other routes of injection, particularly into arteries or veins, have been associated with serious tissue injury.
Regardless of where on the body the drug is injected, promethazine has the potential to occasionally cause chemical irritation and in rare cases severe tissue damage at the site of injection, including cases of gangrene. Patients should immediately report any persistent or worsening pain or burning sensation they feel at the site of injection.Reference
NPI Registry, International Classification of Diseases,ICD,HCPCS, , CPT, National Drug Codes,NDC, SNOMED CT, MEDCIN, Medical news, Health news, Healthcare news, General welfare, and healthy living will bring forth a healthy society. This site is not intended to provide medical advice, diagnosis or treatment. Disclosure; This site shows ads compensated for them.
Friday, April 30, 2010
Promethazine is not to be used in children under the age of two years due to the potentially fatal risk of respiratory depression (slowed breathing).
Promethazine is not to be used in children under the age of two years due to the potentially fatal risk of respiratory depression (slowed breathing). Caution should be used when administering promethazine in children aged two and up: health care professionals are recommended to use the lowest effective dose, and the use of other drugs that may also slow breathing should be avoided. Promethazine is not to be injected under the skin (subcutaneously) due to the risk of serious tissue injury. The preferred route of administration for promethazine is by injection directly and deeply into a muscle (deep intramuscular injection). Other routes of injection, particularly into arteries or veins, have been associated with serious tissue injury. Regardless of where on the body the drug is injected, promethazine has the potential to occasionally cause chemical irritation and in rare cases severe tissue damage at the site of injection, including cases of gangrene. Patients should immediately report any persistent or worsening pain or burning sensation they feel at the site of injection.
Labels:
Promethazine,
respiratory depression
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment